Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Advancing the Science to Reduce Tobacco Use & Nicotine Addiction

University of Ottawa

$49,992.00

Effects of Acute Combination Pharmacotherapy on Morning Smoking Abstinence Symptoms in Female Smokers

EF 2009-10

Résumé
It is now widely accepted that tobacco smoking is an addiction and that nicotine is the principal addic-tive component of tobacco. Many habitual smokers find it difficult to quit smoking and females in par-ticular are less successful in quitting. Nicotine replacement treatments (e.g., nicotine gum and patch) improve success rates for smoking cessation but this effect is less apparent in female smokers. Part of nicotine's attraction lies in its ability to stimulate nicotinic brain receptors that increase dopamine in the pleasure "reward" centre of the brain, resulting in increases in positive mood and improvements in information processing, including attention and memory. Increases in nicotine craving and reductions in mood and cognition are common withdrawal symptoms experienced during tobacco abstinence and these symptoms may respond to treatments that increase brain dopamine. This preliminary study will examine the effects of a single dose of two dopamine elevating drugs, Champix and Zyban, on morning smoking withdrawal symptoms in female smokers. The drugs will be administered separately and to-gether, and their effects on withdrawal symptoms, including craving, mood and cognitive problems, will be compared to placebo. As both of these drugs also have the ability to block nicotinic receptors, the study will also assess whether these drugs administered separately or combined dampen the satisfaction and reward experienced with the smoking of a single cigarette. The study will help us to understand the pharmacological basis of smoking withdrawal and will help to improve treatments tailored for female smokers attempting to quit.
Programme
Catalyst Grant: Advancing the Science to Reduce Tobacco Use & Nicotine Addiction
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
191742
Name
Knott Verner J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Projecttitle
Effects of Acute Combination Pharmacotherapy on Morning Smoking Abstinence Symptoms in Female Smokers
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$49,992
Cihrequipment2
$0
Programname2
Catalyst Grant: Advancing the Science to Reduce Tobacco Use & Nicotine Addiction
Keyworddelim
Cognition; Eeg; Erp; Neuropharmacology; Nicotine Addiction
Abstract
It is now widely accepted that tobacco smoking is an addiction and that nicotine is the principal addic-tive component of tobacco. Many habitual smokers find it difficult to quit smoking and females in par-ticular are less successful in quitting. Nicotine replacement treatments (e.g., nicotine gum and patch) improve success rates for smoking cessation but this effect is less apparent in female smokers. Part of nicotine's attraction lies in its ability to stimulate nicotinic brain receptors that increase dopamine in the pleasure "reward" centre of the brain, resulting in increases in positive mood and improvements in information processing, including attention and memory. Increases in nicotine craving and reductions in mood and cognition are common withdrawal symptoms experienced during tobacco abstinence and these symptoms may respond to treatments that increase brain dopamine. This preliminary study will examine the effects of a single dose of two dopamine elevating drugs, Champix and Zyban, on morning smoking withdrawal symptoms in female smokers. The drugs will be administered separately and to-gether, and their effects on withdrawal symptoms, including craving, mood and cognitive problems, will be compared to placebo. As both of these drugs also have the ability to block nicotinic receptors, the study will also assess whether these drugs administered separately or combined dampen the satisfaction and reward experienced with the smoking of a single cigarette. The study will help us to understand the pharmacological basis of smoking withdrawal and will help to improve treatments tailored for female smokers attempting to quit.
Competitiondate
200911
Approvedterm2
1 yr 0 mth
Pinamesdelim
Knott, Verner J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $49,992~ $0~